On September 23, 2022, Jonathan Jorgl has filed a preliminary proxy statement soliciting proxies and urged the shareholders of AIM ImmunoTech Inc; 1) to vote for Robert L. Chioini and Michael Rice to the Company board and withhold for each of the incumbent nominees, 2) to vote against the Company proposal to approve, by non-binding vote, executive compensation at the Company's annual general meeting of shareholders scheduled to be held on November 3, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 USD | +1.06% | -9.61% | -2.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.25% | 21.46M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.31% | 22.2B | |
-16.53% | 21.23B | |
-8.72% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- AIM Stock
- News AIM ImmunoTech Inc.
- Jonathan Thomas Solicits Proxies from the Shareholders